Keyphrases
Association Study
100%
Polymorphism
100%
Antipsychotics
100%
Clinical Response
100%
Response to Antipsychotics
100%
Methylenetetrahydrofolate Reductase (MTHFR)
66%
Treatment Response
50%
C(T)
50%
Dopamine D2 Receptor (DRD2)
33%
Caucasian Patients
33%
DRD3 Ser9Gly
33%
Netherlands
16%
SNP
16%
Association Analysis
16%
Receptor Gene
16%
Clinical Improvement
16%
Positive Psychotic Symptoms
16%
Prescription Drugs
16%
Risperidone
16%
Ordinal Regression
16%
Non-affective Psychosis
16%
Positive Symptoms
16%
Olanzapine
16%
DRD3
16%
HTR2C
16%
HTR2A
16%
Drug Response
16%
Clinical Global Impression
16%
Second-generation Antipsychotics
16%
Pharmacogenetic Study
16%
TaqI
16%
COMT Val158Met
16%
Dopamine D3 Receptor
16%
CGI-I
16%
5-HTR2C
16%
5-HTR2A
16%
INIS
drugs
100%
genes
100%
patients
80%
values
80%
symptoms
40%
carriers
40%
dopamine
20%
receptors
20%
netherlands
20%
Biochemistry, Genetics and Molecular Biology
Candidate Gene
100%
Typical Antipsychotic
100%
Single Nucleotide Polymorphism
25%
Receptor Gene
25%
Drug Response
25%
Pharmacogenetic Testing
25%
Risperidone
25%
Olanzapine
25%
TaqI
25%
Dopamine Receptor D3
25%
Neuroscience
Typical Antipsychotic
100%
Antipsychotic
50%
Positive Syndrome
25%
Receptor Gene
25%
Affective Psychosis
25%
Risperidone
25%
Olanzapine
25%
Dopamine Receptor D3
25%